BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 20498612)

  • 1. Creatinine increases after intravenous contrast administration: incidence and impact.
    Li J; Solomon RJ
    Invest Radiol; 2010 Aug; 45(8):471-6. PubMed ID: 20498612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of contrast nephropathy from cerebral CT angiography and CT perfusion imaging.
    Josephson SA; Dillon WP; Smith WS
    Neurology; 2005 May; 64(10):1805-6. PubMed ID: 15911820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-induced nephropathy after intravenous administration: fact or fiction?
    Katzberg RW; Lamba R
    Radiol Clin North Am; 2009 Sep; 47(5):789-800, v. PubMed ID: 19744594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast-induced acute kidney injury (CIAKI).
    Solomon R
    Radiol Clin North Am; 2009 Sep; 47(5):783-8, v. PubMed ID: 19744593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of theophylline in prevention of radiocontrast media-induced nephropathy.
    Malhis M; Al-Bitar S; Al-Deen Zaiat K
    Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):276-83. PubMed ID: 20228513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Iodinated contrast media and nephropathy. Estimated creatinine clearance for better assessment of renal function and dosage].
    Nyman U; Hietala SO; Hellström M; Aspelin P; Björkdahl P; Albrechtsson U; Magnusson A; Måre K; Törnquist C; Ringertz H; Sterner G; Westberg G; Berne C
    Ugeskr Laeger; 2004 Jun; 166(26-31):2566-72. PubMed ID: 15285166
    [No Abstract]   [Full Text] [Related]  

  • 7. Contrast media-associated nephrotoxicity.
    Rudnick MR; Berns JS; Cohen RM; Goldfarb S
    Semin Nephrol; 1997 Jan; 17(1):15-26. PubMed ID: 9000546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast media induced nephrotoxicity: problems in clinical practice.
    Stacul F; Cova M
    Radiol Med; 2003; 105(1-2):36-41. PubMed ID: 12700543
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of two hemofiltration protocols for prevention of contrast-induced nephropathy in high-risk patients.
    Marenzi G; Lauri G; Campodonico J; Marana I; Assanelli E; De Metrio M; Grazi M; Veglia F; Fabbiocchi F; Montorsi P; Bartorelli AL
    Am J Med; 2006 Feb; 119(2):155-62. PubMed ID: 16443418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-induced nephrotoxicity in renal allograft recipients.
    Ahuja TS; Niaz N; Agraharkar M
    Clin Nephrol; 2000 Jul; 54(1):11-4. PubMed ID: 10939751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The incidence of contrast-induced nephropathy in trauma patients.
    Hipp A; Desai S; Lopez C; Sinert R
    Eur J Emerg Med; 2008 Jun; 15(3):134-9. PubMed ID: 18460952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Water for contrast-induced nephropathy? A thirst for knowledge.
    Pate GE; Webb JG
    J Invasive Cardiol; 2003 Dec; 15(12):703-5. PubMed ID: 14660822
    [No Abstract]   [Full Text] [Related]  

  • 13. [Contrast medica nephropathy. Better understanding of risk markers and follow up needed].
    Sterner G; Hellström M; Lagerqvist B; Aspelin P; Nyman U
    Lakartidningen; 2009 Jun 24-Jul 7; 106(26-27):1737-42. PubMed ID: 19731735
    [No Abstract]   [Full Text] [Related]  

  • 14. Uricosuric action of cholecystographic agents. A possible factor in nephrotoxicity.
    Mudge GH
    N Engl J Med; 1971 Apr; 284(17):929-33. PubMed ID: 5551801
    [No Abstract]   [Full Text] [Related]  

  • 15. Contrast media induced nephropathy: definition, incidence, outcome, pathophysiology, risk factors and prevention.
    Feldkamp T; Kribben A
    Minerva Med; 2008 Apr; 99(2):177-96. PubMed ID: 18431326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of contrast-induced nephropathy.
    McCullough PA; Sandberg KR
    Rev Cardiovasc Med; 2003; 4 Suppl 5():S3-9. PubMed ID: 14668704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of contrast-induced nephropathy in diabetic patients undergoing elective cardiac catheterization or PCI: role of volume-to-creatinine clearance ratio and iodine dose-to-creatinine clearance ratio.
    Worasuwannarak S; Pornratanarangsi S
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S29-34. PubMed ID: 20364554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin therapy reduces contrast-induced nephropathy: an analysis of contemporary percutaneous interventions.
    Khanal S; Attallah N; Smith DE; Kline-Rogers E; Share D; O'Donnell MJ; Moscucci M
    Am J Med; 2005 Aug; 118(8):843-9. PubMed ID: 16084176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Contrast nephropathy and its prevention].
    Skulec R; Bĕlohlávek J; Kovárník T; Linhart A; Aschermann M
    Vnitr Lek; 2003 Feb; 49(2):127-33. PubMed ID: 12728580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No CAN?
    Brinker JA
    Catheter Cardiovasc Interv; 2001 Apr; 52(4):417-9. PubMed ID: 11285591
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.